Showing results (421-430 of 501) with videos related to

Sort By:
Pageof 51
Structure (London, England : 1993)|November 15, 1996
Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug designR A Engh, H Brandstetter, G Sucher, et al.
Diabetes, Obesity & Metabolism|October 9, 2024
Glycaemic outcomes in adults with type 2 diabetes over 34 weeks with the Omnipod® 5 Automated Insulin Delivery SystemGeorgia M Davis, Anne L Peters, Bruce W Bode, et al.
Scientific Reports|February 12, 2021
Identification, heterologous production and bioactivity of lentinulin A and dendrothelin A, two natural variants of backbone N-methylated peptide macrocycle omphalotin AEmmanuel Matabaro, Hannelore Kaspar, Paul Dahlin, et al.
Diabetes Technology & Therapeutics|August 4, 2015
Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home StudyRam Weiss, Satish K Garg, Bruce W Bode, et al.
Diabetes Care|February 14, 2023
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop TherapyGeorgia M Davis, Anne L Peters, Bruce W Bode, et al.
Current Medical Research and Opinion|August 8, 2012
Association of blood glucose levels with in-hospital mortality and 30-day readmission in patients undergoing invasive cardiovascular surgeryLauren J Lee, Matthew F Emons, Sherry A Martin, et al.
Diabetes, Obesity & Metabolism|May 13, 2022
Reduced hypoglycaemia using liver-targeted insulin in individuals with type 1 diabetesRuth S Weinstock, Bruce W Bode, Satish K Garg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Working to improve care of hospital hyperglycemia through statewide collaboration: the Georgia Hospital Association Diabetes Special Interest GroupCurtiss B Cook, Lawrence Stockton, Marianne Baird, et al.
Diabetes Technology & Therapeutics|September 13, 2018
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT StudyHalis Kaan Akturk, Janet K Snell-Bergeon, Amanda Rewers, et al.
Diabetes Technology & Therapeutics|October 17, 2012
Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payersIrl B Hirsch, Stephanie A Amiel, Ian R Blumer, et al.
Pageof 51